Clinical trials
Mitral Valve Insufficiency trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
| Unknown status | 8 |
| Not yet recruiting | 5 |
| Completed | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Anzhen Hospital | 3 |
| Shanghai NewMed Medical Co., Ltd. | 3 |
| Xiang Wei | 3 |
| Hangzhou Valgen Medtech Co., Ltd | 2 |
| Mitrassist Lifesciences Limited Co., Ltd. | 2 |
| Pan Xiangbin | 2 |
| Peijia Medical Technology (Suzhou) Co., Ltd. | 2 |
| Shanghai Shenqi Medical Technology Co., Ltd | 2 |
| Xiamen Cardiovascular Hospital, Xiamen University | 2 |
| Abbott Medical Devices | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mitral Valve Insufficiency | 29 |
| Mitral Valve Stenosis | 3 |
| Atrial Fibrillation | 2 |
| Cardiomyopathy, Hypertrophic | 2 |
| Aortic Valve Disease | 1 |
| Aortic Valve Insufficiency | 1 |
| Aortic Valve Stenosis | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Heart Failure | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.